| Date Filed | Type | Description |
| 06/30/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 425,000 shares
@ $0.021, valued at
$8.9k
Bought 75,000 shares
@ $0.026, valued at
$2k
|
|
| 06/16/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $0.0326, valued at
$13k
|
|
| 05/31/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 126,888 shares
@ $0.0341, valued at
$4.3k
|
|
| 05/02/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 100,000 shares
@ $0.045, valued at
$4.5k
|
|
| 12/07/2022 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 120,000 shares
@ $0.05, valued at
$6k
|
|
| 11/25/2022 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 70,000 shares
@ $0.08, valued at
$5.6k
|
|
| 09/28/2022 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $0.068, valued at
$1.4k
|
|
| 08/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2021 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Converted 74,455,719 shares
@ $0
Granted 259,302 shares
@ $0
Converted 13,849,161 shares
@ $0
Converted 5,672,025 shares
@ $0
Converted 74,456 convertible preferred
@ $0
Converted 13,849 convertible preferred
@ $0
Converted 5,672 convertible preferred
@ $0
Granted 513,953 options
@ $0.1626, valued at
$83.6k
|
|
| 11/23/2020 |
4
| Trieu Vuong (CEO) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Bought 50,500 shares
@ $0.19, valued at
$9.6k
|
|
| 03/27/2020 |
4
| Trieu Vuong (CEO) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Bought 3,000 shares
@ $0.12, valued at
$360 |
|
| 05/02/2019 |
3
| Trieu Vuong (CEO and Chairman of the Board) has filed a Form 3 on MATEON THERAPEUTICS INC |
| 10/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2018 |
4
| Trieu Vuong (Executive Chairman) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 2 convertible preferred
@ $0.5, valued at
$1.1
Granted 16,875 options to buy
@ $0.55, valued at
$9.3k
Converted 35 convertible preferred
@ $0.5, valued at
$17.3
Converted 258,825 options to buy
@ $0.55, valued at
$142.4k
Converted convertible notes
@ $5000, valued at
$0
Converted 115 convertible preferred
@ $0.5, valued at
$57.3
Converted 859,725 options to buy
@ $0.55, valued at
$472.8k
Converted options to buy
@ $5000, valued at
$0
Converted 19 convertible preferred
@ $0.5, valued at
$9.5
Converted 142,500 options to buy
@ $0.55, valued at
$78.4k
Converted options to buy
@ $5000, valued at
$0 |
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/23/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/22/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/31/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |